DVHGF (Devonian Health Group) Total Equity: $5.74 Mil (As of Jan. 2026)


DVHGF Devonian Health Group Inc DVHGF
49 GF Score
Price $7.00
GF Value $3.02
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Devonian Health Group Total Equity?

Devonian Health Group DVHGF 49 Total Equity is $5.74 Mil as of Jan. 2026. GuruFocus rates DVHGF with a GF Score™ of 49/100 and a GF Value™ of $3.02 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Devonian Health Group's total equity for the quarter that ended in Jan. 2026 was $5.74 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Devonian Health Group Total Equity Historical Data

* Premium members only.

The historical data trend for Devonian Health Group's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Devonian Health Group Total Equity Chart

Devonian Health Group Annual Data
Trend Jun16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 12.58 10.78 10.11 6.67

Devonian Health Group Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.48 6.32 6.67 6.86 5.74
DVHGF
49GF Score
Devonian Health Group Inc DVHGF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Devonian Health Group Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Devonian Health Group's Total Equity for the fiscal year that ended in Jul. 2025 is calculated as

Total Equity=Total Assets(Q: Jul. 2025 )-Total Liabilities(Q: Jul. 2025 )
=11.562-4.889
=6.67

Devonian Health Group's Total Equity for the quarter that ended in Jan. 2026 is calculated as

Total Equity=Total Assets(Q: Jan. 2026 )-Total Liabilities(Q: Jan. 2026 )
=6.947-1.211
=5.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $5.74 Mil mean?
Devonian Health Group (DVHGF) has a Total Equity of $5.74 Mil as of Jan. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Devonian Health Group and its competitors.
Is Devonian Health Group's Total Equity too high?
Devonian Health Group's current Total Equity is $5.74 Mil. Overall, Devonian Health Group has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Devonian Health Group's Total Equity compare to VRTX and REGN?
Devonian Health Group's Total Equity of $5.74 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Devonian Health Group and its competitors. Devonian Health Group's current Total Equity is $5.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Devonian Health Group stock overvalued right now?
Based on GuruFocus' analysis, Devonian Health Group (DVHGF) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.02, compared to a current price of $7.00 — trading 131.8% above its estimated fair value. The current Total Equity is $5.74 Mil. Devonian Health Group's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Devonian Health Group (DVHGF), the current Total Equity is $5.74 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Devonian Health Group (DVHGF) Overvalued in 2026?

Based on GuruFocus' analysis, Devonian Health Group stock appears to be overvalued. The current stock price of $7.00 is trading 131.8% above its estimated GF Value™ of $3.02. GuruFocus considers Devonian Health Group to be Significantly Overvalued.

Key valuation signals for DVHGF:

  • Total Equity: $5.74 Mil
  • GF Value™: $3.02 vs. price of $7.00 (131.8% above fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the DVHGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Devonian Health Group Business Description

Other Exchanges GSD:Canada
Address 360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.
49GF Score

Get the complete analysis for DVHGF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.00
Price
$3.02
GF Value